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Abstract
Optical coherence tomography angiography (OCTA) is a revolutionary method in the visualization of the vascular system in
different retinal and choroidal layers. During the last 4 years since the commercial availability of different OCTA devices,
attempts have been made to utilize this technology in various aspects of ocular oncology from the differentiation of benign
and malignant lesions to assisting in evaluation of post-treatment complications, such as radiation retinopathy. However,
current OCTA technology is restricted by various artefacts and inherent limitations, some of which are more pronounced in
the presence of elevated tumoural lesions. Imminent advancements in OCTA systems and image acquisition processes
promise a great potential for application of OCTA in ocular oncology.
Methodology
Different combinations of search phrases, including “optical
coherence tomography angiography (OCTA)”, “Choroidal
tumours”, “ocular oncology”, “uveal melanoma”, “Chor-
oidal melanoma”, “choroidal nevus”, “melanocytoma”,
“choroidal haemangioma”, “choroidal osteoma”, “choroidal
metastasis”, “radiation retinopathy” and “iris” were used for
searching PubMed, Scopus and Google Scholar in June
2019 to retrieve articles from 2014. The abstract of the
articles was reviewed regarding relevancy to the topic, and
the full text of related papers was retrieved for
further analysis. Review of non-English material was lim-
ited to the available English abstract. A secondary literature
search was conducted in September 2019 before the
submission.
OCTA is a novel, non-invasive and revolutionary mod-
ality in ocular vascular imaging [1]. In contrast to the
conventional two-dimensional approaches, such as fluor-
escein angiography (FA) and indocyanine green (ICG)
angiography, OCTA provides depth-resolved volumetric
information about the microvessels of the choroid and retina
without the need for a contrast media [2, 3].
OCTA is an excellent choice to visualize choroidal
vasculature, especially in situations in which serial ima-
ging could be beneficial in follow-up and management of
the disease, considering the fact that other options, such as
FA and ICGA, are time consuming and invasive that
might be inconvenient for the patient [3]. In addition,
the 3D data, made available by the OCTA, help with
more accurate localization of the abnormal vessels, and
provide the clinician with the closer inspection of the deep
retinal vasculature [4]. Several studies have shown the
ability of the OCTA imaging in depicting vascular
alterations in different retinal, choroidal and optic nerve
diseases [5–9].
Traditionally, the diagnosis of posterior segment tumours
relies on the clinical presentation, ultrasonography and dye-
based angiographies. However, differentiation of the true
nature of the mass may sometimes pose significant chal-
lenges for the physicians. Intrinsic tumoural vasculature
may help to differentiate the intraocular tumours [10]. The
treatment process may affect the vasculature of the tumour
and the surrounding tissue that could be appreciated in
detail with OCTA. During the last 4 years, a considerable
amount of studies reported OCTA applications to describe
different characteristics of ocular tumours. The aim of this
study is to review the published articles on the role of the
OCTA in intraocular tumours.
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Choroidal nevus is a relatively common tumour, particu-
larly in Caucasian individuals, with an estimated prevalence
of 0.2–30% in different reports [11]. Choroidal malignant
melanoma (CHMM) is the most common primary intrao-
cular malignancy [12]. It has been shown that some cases of
CHMM develop from the pre-existing nevi and others do
not [13, 14]. Melanocytoma is another benign entity in this
group, and is usually located juxtapapillary [15].
Diagnosis
Malignant melanoma is considered to be a sight- and life-
threatening tumour, and based on the results of the Colla-
borative Ocular Melanoma Study, detection of CHMM in
early stages with small dimensions yields a better outcome
in terms of both survival and anatomical prognosis [16].
En face OCTA has been shown to have an acceptable
reliability in the determination of longitudinal and perpen-
dicular dimensions comparing with the fundus photo with
good intra- and inter-rater consistency [17]. In a study of 71
eyes, the visibility of nevus in en face OCTA was 79.5%.
Moreover, the thickness greater than 120 μm was associated
with darker masses in en face OCTA, which could be
interpreted as a prognostic factor [18] (Fig. 1).
Clinically, small choroidal melanoma can be dis-
tinguished from choroidal nevus based on the tumour
thickness, presence of subretinal fluid, orange pigment and
visual symptoms in addition to the peripapillary location of
the tumour, which are all in favour of malignant melanoma
[13]. Acoustic hollowness in ultrasonography and the
absence of both halo and drusen are other supplementary
findings [13]. However, sometimes a diagnostic challenge
appears in differentiating small choroidal melanoma from a
choroidal nevus. There is no single modality to successfully
distinguish these two entities from each other in all clinical
occasions, and multimodal imaging is more effectual [19]. It
is hypothesized that malignant transformation of an existing
nevus is accompanied by the formation of new and aberrant
vessels. Apart from the transformation, complex vascular
networks are also usually seen in de novo cases of CHMM
[20]. Previously, an effort was made to demonstrate such
intrinsic vascularity in some cases in conventional angio-
graphy, which was entitled as “double circulation” [21, 22].
It seems rational that OCTA could be helpful in visualization
of the vascular loops and networks in CHMM. Maloca et al.
[23] implemented an experimental method in speckle noise-
free 1050-nm-swept-source OCT for detection of choroidal
vessels in small choroidal nevi. Although due to technical
issues, the angiography was limited to Haller’s and Sattler’s
layers, their study showed that choroidal vasculature was
transformed in the majority of cases. Central signal voids
were also noted in most cases in the area of choroidal
tumour, probably due to blockage and/or absorption by the
heavy pigmented lesion, or the small size of the tumour’s
vascular network. Radial vessels at the periphery of the
tumour were another notable finding, and their calibre was
related to the tumour size. In the case of a very small nevus,
the choroidal vasculature was completely normal [23].
Further efforts have been made to find differentiating
features in OCTA of choroidal melanoma in comparison
with choroidal nevus. Toledo et al. reported qualitative
assessment of melanocytic lesions, including choroidal
nevus with different risk factors for malignancy and frank
CHMM, and found that hyperreflective encompassing rings
and the presence of intrinsic hyporeflective plexus are
indicative of malignant melanocytic lesions [24]. However,
not all choroidal melanomas exhibited these features, or
were they unique to malignant lesions (Fig. 2).
Ghassemi et al. attempted to differentiate posterior pole
choroidal nevus from small choroidal melanoma up to the
Fig. 1 Choroidal nevus.
a Colour fundus photograph of
the left eye showing a flat,
pigmented and well-demarcated
subfoveal nevus. b OCTA
B-scan and en face image of
choriocapillaris slab show
normal vascular flux over the
lesion with lack of significant
intrinsic vasculature within
the nevus.
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thickness of 3.5 mm, using OCTA. Both melanoma and
nevus were identified as hypovascular masses in OCTA
imaging, probably due to signal attenuation by the pigment.
The concept of surface microvasculature (SMV) was
introduced by the authors as a quantitative indicator to
distinguish the two entities. The SMV measurement was
conducted on the choroidal capillary layer overlying the
choroidal mass that was diminished compared with the
corresponding surface to the fellow eye in cases of chor-
oidal melanoma, and was intact in nevi. Peripheral feeding
vessels were also more prominent in malignant lesions [25].
Similarly, Garcia-Arumi Fuste et al. performed a com-
parative study on 18 choroidal nevi and 18 choroidal mel-
anomas. They reported that the irregular contour of mass
encompassed a hyporeflective area in choriocapillaris-
overlying melanoma cases as opposed to hyperreflective
choriocapillaris with irregular margins in choroidal nevus.
In addition, in 45% of melanoma patients, OCTA was able
to disclose abnormal vasculature, such as loops and thick
vessels within the tumour [26].
Cennamo et al. interpreted the OCTA images of different
choroidal tumours. Melanocytic lesions in their study
included 40 choroidal melanomas, 60 choroidal nevi and 2
optic disc melanocytomas. They reported compression of
choroidal vasculature in all melanocytic tumours, the
absence of blood flow within nevi and melanocytoma and
enhanced visualization of intrinsic vasculature of choroidal
melanoma with a thickness of less than 3 mm [27].
The last two studies were limited by the thickness and
location of the tumour, the presence of subretinal fluid and
the patients’ cooperation. By the advent of the new swept-
source OCTA imaging systems, these barriers are overcome
to some extent [3]. Pellegrini and Staurenghi performed
swept-source OCTA on a single case of choroidal melanoma
with a thickness of 5.9 mm in the nasal periphery of the
fundus, and demonstrated that the intrinsic vessels of the
tumour can be disclosed in great detail [28]. The same
authors and their colleagues published another paper in 2018
on swept-source imaging of 22 melanoma cases located
from macular to the ora serrata and having a thickness of
1.5–8.9 mm. The visualization of the tumours’ vasculature
was successfully done in all cases by manual adjustment of
the segmentation slabs. However, the OCTA of the whole
eye was limited in the areas of significant exudative retinal
detachment [29]. The “spider web” pattern of intrinsic vas-
culature in cases of choroidal melanoma, in contrast with the
absence of significant vessels in nevus, is suggested to be
helpful in the differentiation of these two tumours [30].
Effects on retinal and choroidal structures
In addition to disclosure of the vasculature within the
tumours, OCTA can be helpful in recognition of retinal
vasculature alterations caused by the choroidal tumour itself
or its secondary complications (e.g., subretinal fluid).
It is shown that relatively flat nevi do not alter the outer
retinal vessels in OCTA; however, errors in automatic
segmentation of retinal layers disturb the visualization of
the vasculature in the outer retina in thicker tumours [18].
Li et al. demonstrated that there is enlargement of the
deep foveal avascular zone (FAZ) and reduction in super-
ficial and deep capillary vascular density (VD) in untreated
choroidal melanoma cases, irrelevant of the tumour location
and the distance to the fovea. All the mentioned parameters
were reversibly correlated with the presence of subretinal
fluid. The tumours’ dimensions negatively affected the
superficial and deep capillary plexus. The proposed
hypothesis for these observations is secretion of pro-
inflammatory cytokines, such as vascular endothelium
growth factor and subsequent parafoveal ischaemia, or less
probably direct tumour invasion to the outer retina [31].
There is concern regarding accurate measurement of the
Fig. 2 Choroidal melanoma. a
Fundus photo of the left eye
showing an elevated, pigmented
lesion in the macula with
dispersed orange pigment and
subretinal fluid at the inferior
margin. b OCTA B-scan and the
corresponding en face image
demonstrate high vascular flux
and the overlaying SRF and
pigment epithelial detachment
associated with outer retina layer
disorganization in the
corresponding OCT.
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deep FAZ by the OCTA, especially in areas of intraretinal
and subretinal fluid, and increased thickness of the retina. In
addition, projection artefacts in retinal pigment epithelium
and choroidal layers are more pronounced in the presence of
subretinal fluid.
In another study with the use of automated measure-
ments, the macular features of choroidal nevi and melanoma
were compared against each other. In choroidal nevi, the
FAZ and VD parameters were intact in comparison with the
healthy fellow eye, except for a significant reduction of
deep VD in tumours with three or more risk factors for
growth. On the other hand, superficial and deep VD was
diminished in eyes with choroidal melanoma in both
macular and extramacular location of the malignant tumour.
However, the changes in deep FAZ were observed only in
macular melanomas [32]. The difference in alteration of
deep FAZ based on the location of the tumour was probably
due to the homogeneous distribution of the masses in the
fundus in contrast to the macular location of the tumours.
Another application of OCTA is assistance in the diag-
nosis of choroidal neovascularization (CNV) associated
with choroidal nevi. Cicinelli et al. discussed a case of
polypoidal with a concomitant peripapillary nevus. The
OCTA en face imaging revealed the irregular branching of
the new vessels and the hyporeflective areas corresponding
to hyalinized polyps with the dimensions of the lesion
appearing larger in OCTA than FA and ICGA [33]. A larger
retrospective case series by Pellegrini et al. also illustrated
that the sensitivity of OCTA in the disclosure of CNV
associated with nevus is more than FA and ICG imaging
(100% vs. 90% and 83%, respectively) [34]. Recently, it has
been proposed that avascular zones in OCTA images of
optic nerve head in eyes with peripapillary melanocytoma
correlate with the location of the visual field defect, indi-
cating that these tumours may disturb the circulation of the
optic disc [35] (Fig. 3).
Post-treatment changes of intrinsic tumour
vasculature
Currently, the mainstay of treatment of choroidal melanoma
is radiotherapy, most commonly brachytherapy or proton
beam [36]. Considering the high nutritional need of grow-
ing malignant tumour, investigation of intrinsic vasculature
can be a potential indicator of response to treatment or
possibly can be beneficial in highlighting the areas in risk of
future growth. Cennamo et al. demonstrated that in com-
parison with pre-treatment measurements, there is a sig-
nificant reduction in vessel content and blood flow of the
tumours within 1 year after ruthenium-106 plaque bra-
chytherapy [37] (Fig. 4).
In our experience, photodynamic therapy (PDT) and
transpupillary thermotherapy (TTT) for treatment of small
melanoma have similar effects and result in significant
dropout in central tumour vasculature and the overlying
choriocapillaris (Fig. 5).
Post-treatment complications
Radiation retinopathy (RR) is the delayed and major com-
plication of globe conservation therapy by brachytherapy
and proton radiation. Prominent involvement of retinal
vasculature makes this entity a perfect candidate for eva-
luation by OCTA. Veverka et al. [38] proposed a grading
system based on multimodal imaging including OCTA that
was comparable with Horgan modification [39] of the Finger
grading system and even more comprehensive. It was shown
that OCTA is capable of displaying FAZ enlargement and
capillary dropout in RR before the appearance of well-
known signs in ophthalmoscopy or spectral domain OCT
imaging. However, as discussed in that article the ability of
OCTA to accurately visualize retinal vessels is impaired by
the presence of severe oedema.
Fig. 3 Optic disc melanocytoma. a Jet-black pigmented lesion
overhanging on the nasal part of the disc. b After manual correction of
segmentation error, the en face OCTA montage image demonstrates
areas of signal void and heterogeneously distributed sparse intrinsic
vasculature within the tumour possibly due to the masking effect of
pigments.
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OCTA can also be helpful in the prediction of visual
acuity in patients with radiation maculopathy. In a multi-
variate analysis, Matet et al. reported that the visual acuity
was correlated with FAZ size, deep VD and disorganization
of deep capillary plexus. There was concern that the mea-
surement of deep VD was confounded by the masking
effect of the overlying oedema, but the results were
reconfirmed after including the macular thickness in the
analysis [40].
Shields et al. reported OCTA images of a combination of
cases with and without clinically evident RR following I-
125 plaque therapy. There was a significant capillary
dropout in superficial and deep plexus, in addition to a
decrease in VD of choriocapillaris at the tumours’ margins.
The enlargement of FAZ and a universal decrease in par-
afoveal VD were other prominent findings [41].
In a study of 112 irradiated eyes without clinical or OCT
evidence of RR, 17 months after brachytherapy, OCTA
revealed a decrease in the density of parafoveal superficial
and deep capillary plexus in spite of the normal FAZ size
compared with the healthy fellow eye. It was concluded that
the parafoveal ischaemia evident by the OCTA could be a
harbinger of RR [42]. However, the measurements in these
last three studies were based on a customized method
developed by the authors since the articles were published
before the recent developments in built-in standard software
for the measurement of capillary density.
Cennamo et al. also showed that the VD is diminished
following ruthenium-106 plaque therapy at superficial
plexus [37]. No effective method was discussed in their
study for the reduction of projection artefacts that might
influence the density measurements.
The same clinical picture was reported by Sellam et al.
who performed OCTA in proton beam-treated eyes
36 months after treatment. In their study, in order to
eliminate segmentation and projection artefacts the mea-
surement of VD was conducted on the whole retina. Ima-
ging abnormality was reported in all cases, and a significant
reduction in VD was disclosed in treated eyes in compar-
ison with healthy subjects. The choroid was also affected,
and black areas of “signal void” in choriocapillaris, areas of
vascular dilation as well as vanishing vessels were dis-
played in OCTA imaging [43].
Based on the mentioned studies, OCTA can be a valu-
able tool in early detection of RR. Rarefaction of retinal
vasculature both in superficial and deep capillary plexuses
in addition to FAZ enlargement precedes future develop-
ment of radiation maculopathy and decreased vision.
Choroidal haemangioma
Circumscribed choroidal haemangioma (CHH), a benign
hamartomatous vascular lesion, can cause sudden or gradual
visual loss in young patients typically aged 20–40 years [44].
Diagnosis
The hypervascularity of choroidal haemangioma makes it a
perfect candidate for evaluation by OCTA. All studies in the
literature are focused on the circumscribed form of chor-
oidal haemangioma, probably due to the presence of normal
choroidal vasculature as an internal control for comparison.
Although CHH is a vascular tumour, prominent intrinsic
tumour vessels or feeder vessels are not seen ophthalmos-
copically. The main finding in OCTA images is irregularly
organized intertwined large-calibre vessels surrounded by a
circular vascular arcade that acts as the origin of radial
Fig. 4 Choroidal melanoma following Ru-106 plaque radio-
therapy. a Colour fundus photograph of the left eye showing a good
chorioretinal scar around the pigmented and well-demarcated mass 1
year after brachytherapy. OCTA scan rarefaction of the capillary
plexus, both at superficial (b) and deep (c) layers with enlargement and
loss of boundary of the foveal avascular zone, is evident.
Optical coherence tomography angiography (OCTA) applications in ocular oncology
vessels entering the tumour [27, 45, 46]. The signal void
formation within the mass might be indicative of shadowing
by pigment epithelium or the fringe artefact caused by
signal attenuation of deeper layers or very slow blood flow
within the vessels [45, 47] (Fig. 6).
Effects on retinal and choroidal structures
Studies have shown that in case of circumscribed CHH, the
abnormality of choroidal vasculature is limited to the zone
occupied by the tumour and neighbouring choriocapillaris
and other larger vessels appear normal [48].
Sioufi et al. showed that significant changes in deep
retinal capillary plexus were exclusive for cases of cir-
cumscribed CH with a previous or concurrent history of
subretinal or intraretinal fluid. There was no significant
enlargement of FAZ area or reduction in superficial
retinal capillary VD in simple or complicated cases of
CH [48].
Post-treatment changes of intrinsic tumour
vasculature
There are many treatment modalities available for man-
agement of circumscribed CH including laser photo-
coagulation, TTT, PDT, radiotherapy and observation for
asymptomatic patients [49]. Chawla et al. reported their pre-
and post-treatment findings on CHH managed by
frequency-doubled Nd-YAG (532 nm) laser. It was
observed that Nd-YAG laser does not affect the intrinsic
tumour vasculature; however, the irreversible destruction of
the overlying choriocapillaris was observed. It is interesting
that with the atrophy of choriocapillaris, the visualization of
deeper intratumoral vessels is even enhanced [50]. These
findings were in favour of Gass’s theory that the main goal
of laser therapy is approximating the oedematous retina to
the underlying tissue in order to improve the absorption of
the fluid [51]. Laser photocoagulation does not seem to
have any effects on the dimensions of the tumour [50].
Fig. 6 Circumscribed
choroidal haemangioma. a
Fundus photo demonstrates an
amelanotic submacular mass. b
En face choroidal OCTA and B-
scan image show visible large-
calibre intrinsic vessels with
intervening areas of signal void
and high vascular flux over the
haemangioma.
Fig. 5 Small choroidal
melanoma following
transpupillary thermotherapy.
a Fundus photo disclosing a
slightly elevated pigmented
lesion underwent transpupillary
thermotherapy (TTT) with areas
of subretinal fibrosis and RPE
changes. b Retinal layer
disorganization with significant
dropout of tumour vasculature
and the overlying
choriocapillaris is evident in the
corresponding OCTA scan.
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OCTA analysis of post-PDT tumours revealed that as
early as 3 days after treatment, the large-calibre intrale-
sional vasculature appears dark probably due to throm-
bosis and absence of blood flow caused by PDT.
However, 7 days later, the vessels recanalize but to a
calibre slightly smaller than pre-treatment imaging. The
main limitation of this study was the lack of quantitative
measurements to accurately illustrate the long-term
changes made by PDT [52].
In Cennamo et al.’s study, in spite of the fact that pro-
jection artefact was not addressed by the authors, the flow
and VD within the tumour demonstrated a significant
reduction 1 year after brachytherapy of circumscribed CHH
by ruthenium-106. An actual decrease in the size of the
tumour was also observed [53].
Post-treatment complications
As mentioned earlier, atrophy of choriocapillaris in the
region of laser photocoagulation therapy is readily inter-
preted by OCTA [50]. In addition, the changes associated
with RR as a side effect of brachytherapy are discussed in
previous sections.
Choroidal osteoma
Choroidal osteoma is a rare, benign, typically unilateral
tumour that usually occurs in healthy young females. The
natural history of choroidal osteoma is quite variable with
reports of growth, spontaneous resolution, de-ossification,
subretinal fluid and development of CNV [54–56]. CNV
is the main reason for reduced visual acuity in these
patients [57].
Diagnosis
The diagnosis of choroidal osteoma is clinical and is con-
firmed by ultrasound sonography [10]. Cennamo et al.
reported a fine vascular network in uncomplicated choroidal
osteomas, however, the intralesional vascularity had a
lesser extent compared with more vascular tumours, such as
choroidal haemangioma [27]. There are also reports of signal
void in choriocapillaris of the area occupied by choroidal
osteoma [58] that may reflect the difference in the ability of
different devices in the visualization of deeper vasculature.
The major application of OCTA in choroidal osteoma is
assistance in the diagnosis of associated CNV, which will be
discussed in the next section (Fig. 7).
Effects on retinal and choroidal structures
The symptoms in choroidal osteoma are usually associated
with subretinal fluid caused by the tumour itself or by the
CNV [44]. One of the first reports on OCTA in choroidal
osteoma accompanied by CNV is published by Azad et al.
[59]. The superficial reticular pattern of dilated vessels of
CNV was clearly visible by means of OCTA. Also, the
additional information about the multiplicity of feeding
vessels of the CNV complex helped in treatment planning,
rendering laser photocoagulation a less suitable choice [59].
In addition, OCTA is beneficial in disclosing type 2 CNV in
outer retina of cases that visualization by FA is obscured by
the hemorrhage [60].
Post-treatment changes
Anti-vascular endothelial growth factor (anti-VEGF) ther-
apy has become the standard of care for the management of
Fig. 7 Choroidal osteoma. a
Fundus photograph represents a
circumpapillary amelanotic mass
with pseudopod-like projections
and areas of ossification. b
OCTA depicts quiescent
choroidal neovascularization
lesion associated with choroidal
osteoma (red arrow) at the outer
retinal slab. (Colour figure
online).
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CNV, irrespective of the underlying mechanism. The partial
regression of CNV associated with osteoma following
intravitreal injections of anti-VEGF is documented both
qualitatively [58] and quantitatively [60, 61]. On the other
hand, anti-VEGF does not seem to affect the intrinsic vas-
culature of the tumour itself [61].
Choroidal metastases
Choroidal metastasis is the most common cause of intrao-
cular malignancy. In the absence of a reliable history of
systemic cancer (e.g., subclinical lung cancer), the con-
undrum of diagnosis can be a challenge for the ocular
oncologist. There are many different modalities useful in the
differentiation of metastasis from other choroidal masses
[62]. The reports regarding OCTA findings in choroidal
metastasis are scarce and most of them counter-intuitively
report signal void and hypovascularity in the regions of CM
[27, 62]. It is hypothesized that lack of blood flow within
the metastatic tumour might be due to the shadowing arte-
fact of the overlying retinal oedema and pigment epithe-
lium, or the high velocity of blood flow within the tumour’s
vasculature (i.e., fringe effect) [62]. However, there are also
reports of the observation of thick anastomotic vessels
alongside thinner vasculature and hyporeflective avascular
regions in OCTA images acquired by “OCT micro-
angiography-complex” algorithm [24] (Fig. 8).
Miscellaneous posterior segment tumours
In addition to aforementioned tumours, OCTA imaging has
been performed in various other intraocular tumours. In a
photo essay by Hong and Shields, en face OCT and OCTA
were proved useful in the demonstration of the fact that
vascular traction and dragging are present in all retinal
levels of a case with combined hamartoma of the retina and
retinal pigment epithelium [63]. In addition to discernible
rarefaction of capillary plexuses and FAZ area, quantitative
analysis has also shown that there is a significant reduction
of VD in superficial and deep retinal plexus and chor-
iocapillaris in comparison with healthy subjects. The
majority of these changes have been reported to be rever-
sible upon vitrectomy of the involved eyes [64].
The diagnosis of juxtapapillary hemangioblastoma can
be challenging regarding the lack of feeder or draining
vessels and the less probability of association with Von
Hippel-Lindau disease than peripheral lesions [65]. It is
shown that in OCTA, the exact localization of the tumour to
the retina is possible. Hypervascularity of the tumour is also
evident by a dense organization of capillary plexus in en
face images [66]. Theoretically, visualization of intrinsic
vasculature in peripheral tumours can be beneficial in
monitoring of treatment response [24].
In another novel application of OCTA in ocular oncol-
ogy, macular microischaemia was evaluated after intrave-
nous chemotherapy as the mainstay treatment for
retinoblastoma. The study showed that in comparison with
the control group, there was a significant decrease in VD of
deep retinal capillary plexus in both involved and tumour-
free eyes 10 years after intravenous chemotherapy. Other
measured parameters including visual acuity, central
macular thickness, VD of superficial plexus and chor-
iocapillaris and FAZ area were similar to the healthy control
group [63]. Although it should be noted that the retro-
spective nature of the study limits its result-derived con-
clusions, and perhaps with the likely introduction of
handheld OCTA in the future, prospective investigations in
young children might be feasible.
Fig. 8 Choroidal metastasis.
a Fundus photo of a patient with
a history of metastatic breast
cancer disclosing amelanotic
elevated lesion along the inferior
arcade with subretinal fluid
detaching the fovea. b The en
face OCTA at the choroidal
level of the corresponding lesion
demonstrates an area of signal
void (asterisk). The black
crescent at the edge of en face
images is caused by out-of-
register artefact.
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Anterior segment tumours
Currently, with the manipulation of offset and manual focus
changing, OCTA imaging of the anterior segment is pos-
sible with some commercially available retinal devices [67].
OCTA has revealed that iris microhemangioma is located at
the posterior iris stroma and is fed by normal vasculature of
the iris [68].
Iris haemangioma is detected anterior to normal radial
vessel and appears as a dilated vessel with U-shaped course
from the peripheral iris, forming a tortuous loop near pupil
and ending again near the limbal area [69]. The pinpoint
vessels of ocular surface squamous neoplasia are also
visible in OCTA [67].
In a recent study by Skalet et al. OCTA features of dif-
ferent pigmented lesions of the iris were investigated. The
iris freckle and iris pigment epithelial cyst disclosed no
intrinsic vascularity. The vascularity of Iris nevus was
similar to normal iris stroma. On the other hand, the VD of
iris melanoma was significantly higher than the normal iris
and benign nevi, and the twisty disorganized vasculature of
iris melanoma showed significant regression after bra-
chytherapy [70].
OCTA limitations and future directions
There are several limitations in current OCTA technology,
such as various artefacts, some of which are more sig-
nificant in elevated and occasionally pigmented ocular
lesions [71]. It is reported that at least one type of artefact is
present in almost 90% of OCTA images [72]. Segmentation
error is also more pronounced in the presence of increased
retinal thickness and elevated masses, which can impede
proper quantitative and qualitative assessment of VD in
retinal and choroidal pathologies. Therefore, it is of great
importance to interpret OCTA images along with other the
clinical and imaging findings.
Another concern in eyes with poor visual acuity is the
frequent occurrence of different artefacts that affect the
signal strength and quality of interpretation. In a recent
study by Say et al. in patients with CHMM following pla-
que radiotherapy, at least one major artefact was evident in
73% of cases, and loss of focus was the most common one
[73]. The reduced image quality—which is not uncommon
in eyes with choroidal tumour—can also be detrimental in
quantitative and qualitative assessment of OCTA due to
various imposed artefacts [74].
It is also important to know that with the increase in the
operating wavelength (1050 nm of anterior segment OCT
vs. 840 nm of AngioVue OCTA), the penetration of the
study light is better in pigmented lesions. However, with
darkly coloured iris or heavily pigmented tumour of the iris,
the applicability of anterior segment OCTA is limited [70].
With the anticipated future developments of better device
algorithms and availability of wide-field SS OCTA better
visualization of different ocular tumours is expected. Larger
studies with an extensive sample size of different choroidal
tumours are needed to elaborate the application of OCTA in
ocular oncology further. Artificial intelligence is another
high-end technology that can be beneficial in categorizing
OCTA findings of choroidal lesions, and improvement of
layer segmentation in the presence of an elevated mass
disturbing the normal anatomical architecture.
Conclusion
OCTA imaging is a high-resolution and non-invasive
modality that is useful in the disclosure of blood flow,
especially in deeper retinal and choroidal layers, which is
usually masked by the overlying structures in conventional
angiography. This feature of OCTA is helpful in differ-
entiation, treatment planning and follow-up of the intrao-
cular tumours. The swept-source technology of OCTA
seems more beneficial in choroidal tumours due to its ability
to visualize deeper structures. With optimization of OCTA
in imaging of peripheral retina (wide-field OCTA), the
applicability of this modality will expand in ocular
oncology.
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